Skip to main content
FinSpry Logo
FinSpry
ATYR logo
ATYR
(NASDAQ)
aTyr Pharma, Inc.
$0.85-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

aTyr Pharma (ATYR) Stock Price & Financial Analysis

aTyr Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.81 - $0.87
52-Week High$7.29
52-Week Low$0.64
Open$0.84
Volume700.70K
Average Volume (3M)700.70K
Market Cap78.75M
Shares Outstanding92.99M
Price to Sales (P/S)416.38
Price to Book (P/B)1.17
EV/EBITDA-1.06
Revenue (TTM)190.00K
Net Income (TTM)-74.12M
Free Cash Flow (TTM)-62.06M
EPS (TTM)$-0.76
Profit Margin-39009.47%
Operating Margin-40856.32%
Return on Equity (ROE)-109.84%
Debt to Equity0.18
50-Day MA$0.87
200-Day MA$2.23
52-Week Change-70.46%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About aTyr Pharma

What is the current stock price for ATYR?

As of the latest trading session, ATYR stock trades at $0.85. The 52-week range is $0.64–$7.29, with a day range of $0.81–$0.87.

What is the P/E ratio for ATYR?

The P/E ratio (Price-to-Earnings) for ATYR is shown in the Key Statistics section. This valuation metric helps compare aTyr Pharma, Inc. to industry peers.

Does ATYR pay dividends?

aTyr Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ATYR?

Based on 1 analyst, the consensus for ATYR is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ATYR?

aTyr Pharma's market capitalization is $78.7M, classifying it as a micro-cap company. aTyr Pharma operates in the Healthcare sector within the Biotechnology industry.